Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference76 articles.
1. Acharya UH, Jeter JM. Use of ipilimumab in the treatment of melanoma. Clin Pharmacol. 2013;5(Suppl. 1):21–7.
2. Tomasini P, Khobta N, Greillier L, Barlesi F. Ipilimumab: its potential in non-small cell lung cancer. Ther Adv Med Oncol. 2012;4:43–50.
3. Abdel-Rahman O, El Halawani H, Fouad M. Risk of gastrointestinal complications in cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Immunotherapy. 2015;7:1213–27.
4. Chandamuri B, Spiegel J, Nicaud M, Hutchins J. Ipilimumab induced enterocolitis: a fatal immune-related event of melanoma treatment. J Gastroenterol Hepatol Res. 2013;2:934–6.
5. Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology. 1978;75:778–82.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献